U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514325) titled 'MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer' on March 18.
Brief Summary: Rationale: External beam radiotherapy (EBRT) is an important cornerstone in treatment to reduce locoregional relapse in high(-intermediate) risk endometrial cancer (EC) patients. MR-guided adaptive radiotherapy (MGART) allows for more accurate delivery of radiation beams to the patients by visualizing and correcting for interfraction motion, with subsequent reduction of safety margins around the radiotherapy plan. Objective: The MASTEC study will investigate the safety of hypofractionated MR-guided adaptive radiotherapy in five fractions...